BT
BioCentury This Week
Jeff Kramer
Summary
BioCentury This Week is hosted by Jeff Kramer covering RNAi, Antisense Oligonucleotides (ASO), Cardiovascular Disease, and Lipoprotein(a).
1episodes
25total claims
12topics covered
1 episodes
Ep. 348 - Biotech's 2026 Catalysts. Plus: China's New Orphan Rules
›Feb 3, 2026
Pivotal Phase 3 data for RNA-based therapies, particularly in cardiovascular disease with the Lp(a)-targeting drug Pella Carson, are expected in 2026, potentially validating new mechanisms and moda...
RNAiAntisense Oligonucleotides (ASO)Cardiovascular DiseaseLipoprotein(a)+16 more